These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9218294)

  • 21. NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice.
    Price SJ; Whittle IR; Ashkan K; Grundy P; Cruickshank G;
    Br J Neurosurg; 2012 Jun; 26(3):331-5. PubMed ID: 22482926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.
    Lin SH; Kleinberg LR
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):343-59. PubMed ID: 18366283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
    Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
    Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas.
    Rao RD; Thomé SD; O'Fallon J; Earle JD; Dinapoli RP; Buckner JC
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):376-84. PubMed ID: 12023142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers.
    Gallia GL; Brem S; Brem H
    J Natl Compr Canc Netw; 2005 Sep; 3(5):721-8. PubMed ID: 16194460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
    Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
    AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort.
    Ono T; Suzuki H; Nanjo H; Shimizu H
    J Neurooncol; 2024 Jul; 168(3):393-404. PubMed ID: 38780714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
    Wen PY
    J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
    Giese A; Bock HC; Kantelhardt SR; Rohde V
    Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.
    Zander E; de Tribolet N; Wagenknecht L
    Acta Neurochir (Wien); 1978; 42(1-2):97-101. PubMed ID: 696446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.
    Sampath P; Rhines LD; DiMeco F; Tyler BM; Park MC; Brem H
    J Neurooncol; 2006 Oct; 80(1):9-17. PubMed ID: 16636748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.
    Barr JG; Grundy PL
    Br J Neurosurg; 2012 Dec; 26(6):818-22. PubMed ID: 22715955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery.
    Roux A; Caire F; Guyotat J; Menei P; Metellus P; Pallud J;
    Neurochirurgie; 2017 Dec; 63(6):433-443. PubMed ID: 29122306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation--incidence, therapeutic strategies, and outcome.
    Dörner L; Ulmer S; Rohr A; Mehdorn HM; Nabavi A
    J Clin Neurosci; 2011 Mar; 18(3):347-51. PubMed ID: 21237660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carmustine-impregnated wafers and their impact in the management of high-grade glioma.
    La Rocca RV; Rezazadeh A
    Expert Opin Pharmacother; 2011 Jun; 12(8):1325-1332. PubMed ID: 21548723
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant glioma: who benefits from adjuvant chemotherapy?
    DeAngelis LM; Burger PC; Green SB; Cairncross JG
    Ann Neurol; 1998 Oct; 44(4):691-5. PubMed ID: 9778271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.